Amwise Diagnostics
Developing patented genetic analysis technology to assist doctors and patients in determining the most appropriate individualized cancer treatment. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Feb 2020.)
Taiwan (HQ)
Authorizing premium user...